These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28060200)

  • 21. Paroxysmal Sympathetic Hyperactivity Syndrome Following Traumatic Brain Injury.
    Compton E
    Nurs Clin North Am; 2018 Sep; 53(3):459-467. PubMed ID: 30100010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Management of Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury.
    Zheng RZ; Lei ZQ; Yang RZ; Huang GH; Zhang GM
    Front Neurol; 2020; 11():81. PubMed ID: 32161563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Clinical Factors and Acute Pharmacological Management.
    Pozzi M; Conti V; Locatelli F; Galbiati S; Radice S; Citerio G; Clementi E; Strazzer S
    J Head Trauma Rehabil; 2015; 30(5):357-63. PubMed ID: 25310291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of paroxysmal sympathetic hyperactivity following severe pediatric brain injury.
    Letzkus L; Keim-Malpass J; Anderson J; Conaway M; Patrick P; Kennedy C
    J Pediatr Rehabil Med; 2018; 11(3):153-160. PubMed ID: 30198878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of the PSH-AM in patients with diffuse axonal injury and autonomic dysregulation: A cohort study and review.
    van Eijck MM; Sprengers MOP; Oldenbeuving AW; de Vries J; Schoonman GG; Roks G
    J Crit Care; 2019 Feb; 49():110-117. PubMed ID: 30415180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of Serum Procalcitonin in Diagnosing Paroxysmal Sympathetic Hyperactivity in Patients with Traumatic Brain Injury.
    Bindra A; Chowdhary V; Dube SK; Goyal K; Mathur P
    Indian J Crit Care Med; 2021 May; 25(5):580-583. PubMed ID: 34177179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroanatomical basis of paroxysmal sympathetic hyperactivity: a diffusion tensor imaging analysis.
    Hinson HE; Puybasset L; Weiss N; Perlbarg V; Benali H; Galanaud D; Lasarev M; Stevens RD;
    Brain Inj; 2015; 29(4):455-61. PubMed ID: 25565392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence and predictive factors of heterotopic ossification in severe acquired brain injured patients during rehabilitation stay: cross-sectional survey.
    Bargellesi S; Cavasin L; Scarponi F; De Tanti A; Bonaiuti D; Bartolo M; Boldrini P; Estraneo A;
    Clin Rehabil; 2018 Feb; 32(2):255-262. PubMed ID: 28805078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine: An Effective Abortive Therapy for Pediatric Paroxysmal Sympathetic Hyperactivity After Hypoxic Brain Injury.
    Raithel DS; Ohler KH; Porto I; Bicknese AR; Kraus DM
    J Pediatr Pharmacol Ther; 2015; 20(4):335-40. PubMed ID: 26380574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paroxysmal sympathetic hyperactivity in pediatric traumatic brain injury: A case series of four patients.
    Deepika A; Mathew MJ; Kumar SA; Devi BI; Shukla D
    Auton Neurosci; 2015 Dec; 193():149-51. PubMed ID: 26277041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxysmal sympathetic hyperactivity after severe brain injury.
    Lump D; Moyer M
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):494. PubMed ID: 25220846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Paroxysmal sympathetic hyperactivity].
    Corell A; Ljungqvist J
    Lakartidningen; 2021 Dec; 118():. PubMed ID: 34914088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How does dysautonomia influence the outcome of traumatic brain injured patients admitted in a neurorehabilitation unit?
    Laxe S; Terré R; León D; Bernabeu M
    Brain Inj; 2013; 27(12):1383-7. PubMed ID: 24102213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paroxysmal Sympathetic Hyperactivity in Children: An Exploratory Evaluation of Nursing Interventions.
    Letzkus L; Keim-Malpass J; Anderson J; Kennedy C
    J Pediatr Nurs; 2017; 34():e17-e21. PubMed ID: 28283208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study.
    Wang D; Su S; Tan M; Wu Y; Wang S
    Front Immunol; 2021; 12():665183. PubMed ID: 33912193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early diagnosis and treatment for burn complicated with severe paroxysmal sympathetic hyper-activity].
    Lou JH; Zhao XK; Li SR; Liu B; Li YC; Zhang J; Wang L; Yang GY; Xiao HT; Xie JF; Lyu T; Li XL; Xia CD
    Zhonghua Shao Shang Za Zhi; 2019 Aug; 35(8):599-603. PubMed ID: 31474040
    [No Abstract]   [Full Text] [Related]  

  • 37. Paroxysmal sympathetic hyperactivity concurrent with hypothalamic injury in a patient with intracerebral hemorrhage: A case report.
    Jang SH; Choi KH
    Medicine (Baltimore); 2022 Aug; 101(32):e30058. PubMed ID: 35960042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxysmal Sympathetic Hyperactivity Rate in Vegetative or Minimally Conscious State after Acquired Brain Injury Evaluated by Paroxysmal Sympathetic Hyperactivity Assessment Measure.
    Lucca LF; Pignolo L; Leto E; Ursino M; Rogano S; Cerasa A
    J Neurotrauma; 2019 Aug; 36(16):2430-2434. PubMed ID: 30887860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spasticity management and resolution of paroxysmal sympathetic hyperactivity in the acute care setting: a case series.
    Edmond A; McKay O; Mehta N; Dabaghian L; Yonclas P
    Brain Inj; 2022 May; 36(6):817-821. PubMed ID: 35608189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Intrathecal Baclofen Therapy for Intractable Paroxysmal Sympathetic Hyperactivity in Patient with Pontine Hemorrhage: A case report.
    Kim HS; Kim NY; Kim YW
    Clin Neuropharmacol; 2018; 41(4):138-141. PubMed ID: 30001249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.